Peptide T improves psoriasis when infused into lesions in nanogram amounts
- 31 October 1991
- journal article
- research article
- Published by Elsevier BV in Journal of the American Academy of Dermatology
- Vol. 25 (4), 658-664
- https://doi.org/10.1016/0190-9622(91)70249-2
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Biology of retroviruses: Detection, molecular biology, and treatment of retroviral infectionJournal of the American Academy of Dermatology, 1990
- Vasoactive intestinal polypeptide stimulates cell proliferation and adenylate cyclase activity of cultured human keratinocytes.Proceedings of the National Academy of Sciences of the United States of America, 1989
- IMPROVEMENT IN AIDS PATIENTS ON PEPTIDE TThe Lancet, 1989
- PEPTIDE TDrugs of the Future, 1989
- Tritiated D-ala1-peptide T binding: A pharmacologic basis for the design of drugs which inhibit HIV receptor bindingDrug Development Research, 1988
- PEPTIDE T[4-8] IS CORE HIV ENVELOPE SEQUENCE REQUIRED FOR CD4 RECEPTOR ATTACHMENTThe Lancet, 1987
- REMISSION OF AIDS-ASSOCIATED PSORIASIS WITH ZIDOVUDINEThe Lancet, 1987
- CD4 receptor binding peptides that block HIV infectivity cause human monocyte chemotaxisFEBS Letters, 1987
- PEPTIDE T IN TREATMENT OF AIDSThe Lancet, 1987
- Octapeptides deduced from the neuropeptide receptor-like pattern of antigen T4 in brain potently inhibit human immunodeficiency virus receptor binding and T-cell infectivity.Proceedings of the National Academy of Sciences of the United States of America, 1986